Additionally, since no TRH analogs has been approved to date for the treatment of depression, the use of DA agonist agents—via stimulation of the TRH-compensatory mechanism—could represent a new therapeutic approach for suicide prevention [5]. The gene discussed is TRH; the disease is depressive disorder.